Matthias Mann obtained his Ph.D. in chemical engineering at Yale, contributing to the Nobel Prize for his supervisor John Fenn for the development of electrospray ionization. Currently, he heads the Proteomics and Signal Transduction department at the Max-Planck Institute of Biochemistry in Munich, while also directing the Proteomics Program at the Center for Protein Research at Copenhagen University.
As a pioneer in his field, Dr. Mann has made numerous groundbreaking technological advances and has developed powerful computational and proteomics workflows for a wide range of biomedical applications, increasingly emphasizing translational research. His team increasingly focuses on clinically relevant questions, such as body fluid proteomics, single-cell level tissue heterogeneity, signaling, and post-translational modifications.
With a remarkable record of over 850 publications, Dr. Mann is among Germany’s most cited researcher, with an h-index of 254 and more than 315,000 citations according to Google Scholar. His mentorship has fostered the success of many researchers, and his group at the MPIB has spurred the formation of three start-up companies.
Dr. Mann’s outstanding contributions have garnered him numerous prestigious accolades, including the Otto-Warburg Medal, Germany’s Leibniz Prize, the Körber European Science Prize, the Louis-Jeantet Foundation Prize for Medicine, the HUPO Distinguished Achievement Award in Proteomic Science, and ‘The Order of Dannebrog Knights Cross’ conferred by the Queen of Denmark.